抗体
试剂盒
多肽
探针
蛋白
组织芯片
组织芯片
乳腺癌，75例，150芯（1.1mm），系列5
- 货号： BRC1505
- 芯片名称： 乳腺癌，75例，150芯（1.1mm），系列5
- 芯片描述： 乳腺癌组织芯片，系列5，不与BRC1501 到BRC1504或BRC1506 到BRC15011重复，150芯，包括正常/良性（5例）和癌（70例）组织 双芯布阵，提供分级，TNM分期，ER，PR，HER2，P53，EGFR，Ki67 IHC数据。
定制服务咨询
| 武汉天德生物病理生物芯片系列-BRC1505 | |||||||||
| 芯片编号 | BRC1505 | ||||||||
| 芯片名称 | BRC1505乳腺癌，75例，150芯（1.1mm），系列5 | ||||||||
| 芯片说明 | 乳腺癌组织芯片，系列5，不与BRC1501 到BRC1504或BRC1506 到BRC15011重复，150芯，包括正常/良性（5例）和癌（70例）组织 双芯布阵，提供分级，TNM分期，ER，PR，HER2，P53，EGFR，Ki67 IHC数据。 | ||||||||
| 点数: | 150芯 | ||||||||
| 例数: | 75例 | ||||||||
| 组织固定方式: | 福尔马林固定24h | ||||||||
| QA/QC: | HE染色和IHC染色 | ||||||||
| 应用: | 常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH)，可以在我们的技术支持页面找到操作流程。 | ||||||||
| 注意事项: | 1.收到产品后请常温保存，并在24个月内使用，2.请在实验前60°烤片30分钟，3.请选择温和的修复方式，以免造成组织脱落。 | ||||||||
| Array Name | Array position | Order | Sex | Age | Anatomic site | Pathology | Nature | Grade | Stage (TNM) |
| BRC1505A | A01 | 1 | F | 50 | Breast | Normal/hyperplasia | Benign | ||
| BRC1505A | A02 | 2 | F | 37 | Breast | Normal/hyperplasia | Benign | ||
| BRC1505A | A03 | 3 | F | 44 | Breast | Fibroadenoma | Benign | ||
| BRC1505A | A04 | 4 | F | 23 | Breast | Fibroadenoma | Benign | ||
| BRC1505A | A05 | 5 | F | 35 | Breast | Fibroadenoma | Benign | ||
| BRC1505A | A06 | 6 | F | 64 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | A07 | 7 | F | 61 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | A08 | 8 | F | 36 | Breast | Invasive ductal carcinoma | Malignant | III | T2N1M0 |
| BRC1505A | A09 | 9 | F | 33 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | A10 | 10 | F | 51 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | A11 | 11 | F | 45 | Breast | Mucinous adenocarcinoma | Malignant | T2N0M0 | |
| BRC1505A | A12 | 12 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | II | T3N1M0 |
| BRC1505A | A13 | 13 | F | 59 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | A14 | 14 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | A15 | 15 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | B01 | 16 | F | 50 | Breast | Normal/hyperplasia | Benign | ||
| BRC1505A | B02 | 17 | F | 37 | Breast | Normal/hyperplasia | Benign | ||
| BRC1505A | B03 | 18 | F | 44 | Breast | Fibroadenoma | Benign | ||
| BRC1505A | B04 | 19 | F | 23 | Breast | Fibroadenoma | Benign | ||
| BRC1505A | B05 | 20 | F | 35 | Breast | Fibroadenoma | Benign | ||
| BRC1505A | B06 | 21 | F | 64 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | B07 | 22 | F | 61 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | B08 | 23 | F | 36 | Breast | Invasive ductal carcinoma | Malignant | III | T2N1M0 |
| BRC1505A | B09 | 24 | F | 33 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | B10 | 25 | F | 51 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | B11 | 26 | F | 45 | Breast | Mucinous adenocarcinoma | Malignant | T2N0M0 | |
| BRC1505A | B12 | 27 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | II | T3N1M0 |
| BRC1505A | B13 | 28 | F | 59 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | B14 | 29 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | B15 | 30 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | C01 | 31 | F | 46 | Breast | Ductal carcinoma in situ | Malignant | TisN0M0 | |
| BRC1505A | C02 | 32 | F | 50 | Breast | Invasive lobular carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | C03 | 33 | F | 51 | Breast | Invasive ductal carcinoma | Malignant | I~II | T1N0M0 |
| BRC1505A | C04 | 34 | F | 57 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | C05 | 35 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | C06 | 36 | F | 50 | Breast | Invasive lobular carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | C07 | 37 | F | 65 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | C08 | 38 | F | 45 | Breast | Mucinous adenocarcinoma | Malignant | T2N0M0 | |
| BRC1505A | C09 | 39 | F | 74 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | C10 | 40 | F | 69 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | C11 | 41 | F | 36 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | C12 | 42 | F | 35 | Breast | Invasive ductal carcinoma | Malignant | III | T2N0M0 |
| BRC1505A | C13 | 43 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | C14 | 44 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | C15 | 45 | F | 55 | Breast | Invasive ductal carcinoma | Malignant | II | T4N1M0 |
| BRC1505A | D01 | 46 | F | 46 | Breast | Ductal carcinoma in situ | Malignant | TisN0M0 | |
| BRC1505A | D02 | 47 | F | 50 | Breast | Invasive lobular carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | D03 | 48 | F | 51 | Breast | Invasive ductal carcinoma | Malignant | I~II | T1N0M0 |
| BRC1505A | D04 | 49 | F | 57 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | D05 | 50 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | D06 | 51 | F | 50 | Breast | Invasive lobular carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | D07 | 52 | F | 65 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | D08 | 53 | F | 45 | Breast | Mucinous adenocarcinoma | Malignant | T2N0M0 | |
| BRC1505A | D09 | 54 | F | 74 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | D10 | 55 | F | 69 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | D11 | 56 | F | 36 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | D12 | 57 | F | 35 | Breast | Invasive ductal carcinoma | Malignant | III | T2N0M0 |
| BRC1505A | D13 | 58 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | D14 | 59 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | D15 | 60 | F | 55 | Breast | Invasive ductal carcinoma | Malignant | II | T4N1M0 |
| BRC1505A | E01 | 61 | F | 60 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | E02 | 62 | F | 48 | Breast | Invasive ductal carcinoma | Malignant | II | T3N1M0 |
| BRC1505A | E03 | 63 | F | 46 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | E04 | 64 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | E05 | 65 | F | 74 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | E06 | 66 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II | T4N1M0 |
| BRC1505A | E07 | 67 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | E08 | 68 | F | 56 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | E09 | 69 | F | 43 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | E10 | 70 | F | 58 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | E11 | 71 | F | 57 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | E12 | 72 | F | 51 | Breast | Papillary adenocarcinoma | Malignant | I | T2N0M0 |
| BRC1505A | E13 | 73 | F | 30 | Breast | Invasive ductal carcinoma | Malignant | II | T3N0M0 |
| BRC1505A | E14 | 74 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | E15 | 75 | F | 42 | Breast | Mucinous adenocarcinoma | Malignant | T2N0M0 | |
| BRC1505A | F01 | 76 | F | 60 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | F02 | 77 | F | 48 | Breast | Invasive ductal carcinoma | Malignant | II | T3N1M0 |
| BRC1505A | F03 | 78 | F | 46 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | F04 | 79 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | F05 | 80 | F | 74 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | F06 | 81 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II | T4N1M0 |
| BRC1505A | F07 | 82 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | F08 | 83 | F | 56 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | F09 | 84 | F | 43 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | F10 | 85 | F | 58 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | F11 | 86 | F | 57 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | F12 | 87 | F | 51 | Breast | Papillary adenocarcinoma | Malignant | I | T2N0M0 |
| BRC1505A | F13 | 88 | F | 30 | Breast | Invasive ductal carcinoma | Malignant | II | T3N0M0 |
| BRC1505A | F14 | 89 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | F15 | 90 | F | 42 | Breast | Mucinous adenocarcinoma | Malignant | T2N0M0 | |
| BRC1505A | G01 | 91 | F | 31 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | G02 | 92 | F | 43 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | G03 | 93 | F | 60 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | G04 | 94 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | G05 | 95 | F | 69 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | G06 | 96 | F | 44 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 |
| BRC1505A | G07 | 97 | F | 30 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 |
| BRC1505A | G08 | 98 | F | 46 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | G09 | 99 | F | 61 | Breast | Invasive ductal carcinoma | Malignant | II | T4N1M0 |
| BRC1505A | G10 | 100 | F | 42 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | G11 | 101 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | G12 | 102 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II | T3N0M0 |
| BRC1505A | G13 | 103 | F | 72 | Breast | Invasive ductal carcinoma | Malignant | II | T4N0M0 |
| BRC1505A | G14 | 104 | F | 38 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | G15 | 105 | F | 65 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | H01 | 106 | F | 31 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | H02 | 107 | F | 43 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | H03 | 108 | F | 60 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | H04 | 109 | F | 40 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | H05 | 110 | F | 69 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | H06 | 111 | F | 44 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 |
| BRC1505A | H07 | 112 | F | 30 | Breast | Invasive ductal carcinoma | Malignant | II~III | T2N0M0 |
| BRC1505A | H08 | 113 | F | 46 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | H09 | 114 | F | 61 | Breast | Invasive ductal carcinoma | Malignant | II | T4N1M0 |
| BRC1505A | H10 | 115 | F | 42 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | H11 | 116 | F | 45 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | H12 | 117 | F | 52 | Breast | Invasive ductal carcinoma | Malignant | II | T3N0M0 |
| BRC1505A | H13 | 118 | F | 72 | Breast | Invasive ductal carcinoma | Malignant | II | T4N0M0 |
| BRC1505A | H14 | 119 | F | 38 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | H15 | 120 | F | 65 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | I01 | 121 | F | 47 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | I02 | 122 | F | 51 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | I03 | 123 | F | 63 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | I04 | 124 | F | 56 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | I05 | 125 | F | 39 | Breast | Invasive lobular carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | I06 | 126 | F | 41 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | I07 | 127 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | I~II | T2N0M0 |
| BRC1505A | I08 | 128 | F | 70 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | I09 | 129 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | I10 | 130 | F | 62 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | I11 | 131 | F | 40 | Breast | Papillary adenocarcinoma | Malignant | TisN0M0 | |
| BRC1505A | I12 | 132 | F | 71 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | I13 | 133 | F | 42 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | I14 | 134 | F | 49 | Breast | Invasive ductal carcinoma | Malignant | III | T2N1M0 |
| BRC1505A | I15 | 135 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | J01 | 136 | F | 47 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | J02 | 137 | F | 51 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | J03 | 138 | F | 63 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | J04 | 139 | F | 56 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | J05 | 140 | F | 39 | Breast | Invasive lobular carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | J06 | 141 | F | 41 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | J07 | 142 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | I~II | T2N0M0 |
| BRC1505A | J08 | 143 | F | 70 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | J09 | 144 | F | 54 | Breast | Invasive ductal carcinoma | Malignant | II | T2N0M0 |
| BRC1505A | J10 | 145 | F | 62 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | J11 | 146 | F | 40 | Breast | Papillary adenocarcinoma | Malignant | TisN0M0 | |
| BRC1505A | J12 | 147 | F | 71 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | J13 | 148 | F | 42 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |
| BRC1505A | J14 | 149 | F | 49 | Breast | Invasive ductal carcinoma | Malignant | III | T2N1M0 |
| BRC1505A | J15 | 150 | F | 50 | Breast | Invasive ductal carcinoma | Malignant | II | T2N1M0 |